Antiretroviral treatment and prevention of mother-to-child transmission of human immunodeficiency virus in women with acquired immunodeficiency syndrome
CAI Ren-Tian1，LU Hong-Zhou1,2,3
1. Shanghai Public Health Clinical Center affiliated with Fudan University, Shanghai 201508, China; 2. Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China; 3. Department of Internal Medicine, Shanghai Medical College, Fudan University, Shanghai 200040, China
Abstract：Since antiretroviral therapy was implemented in pregnant women infected with human immunodeficiency virus (HIV), the success rate of prevention of mother-to-child transmission (PMTCT) of HIV has been increased significantly. And some antiviral drugs, such as efavirenz and tenofovir, have gradually been proven to be safe for pregnant women and fetus. The range of options for PMTCT drugs is increased.
蔡仁田1，卢洪洲1,2,3 . 女性艾滋病患者的抗反转录病毒治疗与人类免疫缺陷病毒母婴阻断[J]. 微生物与感染, 2014, 9(3): 191-196.
CAI Ren-Tian1，LU Hong-Zhou1,2,3. Antiretroviral treatment and prevention of mother-to-child transmission of human immunodeficiency virus in women with acquired immunodeficiency syndrome. JOURNAL OF MICROBES AND INFECTIONS, 2014, 9(3): 191-196.
